EPHX2 and urinary bladder neoplasm: To determine whether the anti-inflammatory effects of sEH inhibition combined with ICI were unique to MB49 bladder tumors and/or the specific ICI used, we next evaluated B16F10 tumors that had been treated with either EC5026, anti-PD-1, a combination of EC5026 and anti-PD-1, or vehicle.